Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...

A new study suggests that two widely used Type 2 diabetes medications—GLP-1 receptor agonists and SGLT2 inhibitors—may help reduce the risk of Alzheimer’s disease and related dementias.

The study supports prior research that found the same thing.

The U.S. Food and Drug Administration on Monday warned consumers and pharmacies that fake versions of Ozempic, a drug to ...

The first GLP-1 pill could be in medicine cabinets sooner than expected. Eli Lilly (LLY) announced Thursday that its daily ...

Certain foods can worsen GI side effects from GLP-1 durgs. Learn which foods to avoid and which to choose instead.

Former speed skater Sarah Lindsay believes injections such as Ozempic and Mounjaro — known ... sick “or even a comeback of a deficiency disease like scurvy”. The illness is caused by a ...

Some celebrities who have spoken out about using the weight loss drug include Oprah Winfrey, Kelly Clarkson, and James Corden ...

She warned that the jabs could make people ill or even a cause a 'comeback of a deficiency disease like scurvy'. Weight loss drugs such as Ozempic, Wegovy and Mounjaro are all injectable GLP-1 ...

None had been diagnosed with Alzheimer disease and related dementias at the start of the study. The researchers discovered that people who took GLP-1 receptor agonists (like Ozempic) or a type of ...

GLP-1 and SGLT2 drugs — could significantly reduce the risk of developing dementia in life, a large new study has found.

Two studies suggested the diabetes/weight-loss drug may have a beneficial side effect—but more work is needed to confirm this.